DGAT1 inhibitors (Novartis)

N/A

Report date: 2025/03/18 18:19:54
NME

Base Information

Drug NameDGAT1 inhibitors (Novartis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsCardiovascular DiseasesPancreatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesPancreatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A